Sara K Dawson1, Lynn A D'Andrea1, Ryan Lau2, Joanne M Lagatta2. 1. Department of Pediatrics, Divisions of Pulmonary and Sleep Medicine, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, Wisconsin, USA. 2. Department of Pediatrics, Division of Neonatology, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, Wisconsin, USA.
Abstract
BACKGROUND: Predischarge capillary blood gas partial pressure of carbon dioxide (pCO2 ) has been associated with increased adverse events including readmission. This study aimed to determine if predischarge pCO2 or 36-week pCO2 was associated with increased respiratory readmissions or other pulmonary healthcare utilization in the year after neonatal intensive care unit (NICU) discharge for infants with bronchopulmonary dysplasia (BPD) discharged with home oxygen, using a standardized outpatient oxygen weaning protocol. METHODS: This was a secondary cohort analysis of infants born <32 weeks gestational age with BPD, referred to our clinic for home oxygen therapy from either from our level IV NICU or local level III NICUs between 2015 and 2017. Infants with major nonrespiratory comorbidities were excluded. Subject information was obtained from electronic health records. RESULTS: Of 125 infants, 120 had complete 1-year follow-up. Twenty-three percent of infants experienced a respiratory readmission after NICU discharge. There was no significant association between predischarge or 36-week pCO2 and respiratory readmissions, emergency room visits, new or increased bronchodilators, or diuretics. Higher 36-week pCO2 was associated with a later corrected age when oxygen was discontinued (<6 months; median, 54 mmHg; interquartile range [IQR], 51-61; 6-11 months; median, 62 mmHg; IQR, 57-65; ≥12 months, median, 66 mmHg; IQR, 58-73; p = .006). CONCLUSIONS: Neither predischarge pCO2 nor 36-week pCO2 was associated with 1-year respiratory readmissions. However higher pCO2 at 36 weeks was associated with a longer duration of home oxygen. Neonatal illness measures like 36-week pCO2 may be useful in communicating expectations for home oxygen therapy to families.
BACKGROUND: Predischarge capillary blood gas partial pressure of carbon dioxide (pCO2 ) has been associated with increased adverse events including readmission. This study aimed to determine if predischarge pCO2 or 36-week pCO2 was associated with increased respiratory readmissions or other pulmonary healthcare utilization in the year after neonatal intensive care unit (NICU) discharge for infants with bronchopulmonary dysplasia (BPD) discharged with home oxygen, using a standardized outpatientoxygen weaning protocol. METHODS: This was a secondary cohort analysis of infants born <32 weeks gestational age with BPD, referred to our clinic for home oxygen therapy from either from our level IV NICU or local level III NICUs between 2015 and 2017. Infants with major nonrespiratory comorbidities were excluded. Subject information was obtained from electronic health records. RESULTS: Of 125 infants, 120 had complete 1-year follow-up. Twenty-three percent of infants experienced a respiratory readmission after NICU discharge. There was no significant association between predischarge or 36-week pCO2 and respiratory readmissions, emergency room visits, new or increased bronchodilators, or diuretics. Higher 36-week pCO2 was associated with a later corrected age when oxygen was discontinued (<6 months; median, 54 mmHg; interquartile range [IQR], 51-61; 6-11 months; median, 62 mmHg; IQR, 57-65; ≥12 months, median, 66 mmHg; IQR, 58-73; p = .006). CONCLUSIONS: Neither predischarge pCO2 nor 36-week pCO2 was associated with 1-year respiratory readmissions. However higher pCO2 at 36 weeks was associated with a longer duration of home oxygen. Neonatal illness measures like 36-week pCO2 may be useful in communicating expectations for home oxygen therapy to families.
Authors: A Greenough; J Alexander; S Burgess; P A J Chetcuti; S Cox; W Lenney; F Turnbull; N J Shaw; A Woods; J Boorman; S Coles; J Turner Journal: Arch Dis Child Date: 2002-01 Impact factor: 3.791
Authors: Usha Krishnan; Jeffrey A Feinstein; Ian Adatia; Eric D Austin; Mary P Mullen; Rachel K Hopper; Brian Hanna; Lew Romer; Roberta L Keller; Jeffrey Fineman; Robin Steinhorn; John P Kinsella; D Dunbar Ivy; Erika Berman Rosenzweig; Usha Raj; Tilman Humpl; Steven H Abman Journal: J Pediatr Date: 2017-06-20 Impact factor: 4.406
Authors: Timothy P Stevens; Neil N Finer; Waldemar A Carlo; Peter G Szilagyi; Dale L Phelps; Michele C Walsh; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Jamie E Newman; Abhik Das; Barbara T Do; Kurt Schibler; Wade Rich; Nancy S Newman; Richard A Ehrenkranz; Myriam Peralta-Carcelen; Betty R Vohr; Deanne E Wilson-Costello; Kimberly Yolton; Roy J Heyne; Patricia W Evans; Yvonne E Vaucher; Ira Adams-Chapman; Elisabeth C McGowan; Anna Bodnar; Athina Pappas; Susan R Hintz; Michael J Acarregui; Janell Fuller; Ricki F Goldstein; Charles R Bauer; T Michael O'Shea; Gary J Myers; Rosemary D Higgins Journal: J Pediatr Date: 2014-04-13 Impact factor: 4.406
Authors: Don Hayes; Kevin C Wilson; Katelyn Krivchenia; Stephen M M Hawkins; Ian M Balfour-Lynn; David Gozal; Howard B Panitch; Mark L Splaingard; Lawrence M Rhein; Geoffrey Kurland; Steven H Abman; Timothy M Hoffman; Christopher L Carroll; Mary E Cataletto; Dmitry Tumin; Eyal Oren; Richard J Martin; Joyce Baker; Gregory R Porta; Deborah Kaley; Ann Gettys; Robin R Deterding Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405